LEADER 01385nam2-2200421---450-
001 990003204490203316
005 20150123125656.0
010   $a978-3-540-79085-3
035   $a000320449
035   $aUSA01000320449
035   $a(ALEPH)000320449USA01
035   $a000320449
100   $a20090311d2009----km-y0itay50------ba
101   $aeng
102   $aNL
105   $a||||||||001yy
200 1 $aAntiviral strategies$fHans-Georg Kräusslich, ralf Bartenschlager editors$gContributors J. Anderson ...[et al.]...[et al.]
210   $aBerlin$cSpringer$d2009
215   $aXI, 379 p.$d24 cm
225 2 $aHandbook of experimental pharmacology$v189
410  0$1001000320432$aHandbook of experimental pharmacology$v, 189$12001
606 0 $aVirologia$2BNCF
676   $a616.0194
702  1$aKRÄUSSLICH,$bHans-Georg
702  1$aBARTENSCHLAGER,$bRalf
801  0$aIT$bsalbc$gISBD
912   $a990003204490203316
951   $a616.0194 ANT$b5062 Farm.$c616.0194$d00197642
959   $aBK
969   $aFAR
979   $aCHIARA$b90$c20090311$lUSA01$h1447
979   $aCHIARA$b90$c20090311$lUSA01$h1447
979   $aCHIARA$b90$c20090311$lUSA01$h1447
979   $aCHIARA$b90$c20090311$lUSA01$h1450
979   $aCHIARA$b90$c20090311$lUSA01$h1452
979   $aPATRY$b90$c20150123$lUSA01$h1256
996   $aAntiviral strategies$91015471
997   $aUNISA